Inferring tumour purity and stromal and immune cell admixture from expression data
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Yoshihara et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“We devised two gene signatures: (1) a ‘stromal signature’ that was designed to capture the presence of stroma in tumour tissue, and (2) an ‘immune signature’ that aimed to represent the infiltration of immune cells in tumour tissue (Supplementary Data 1).”
MethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cited by
Items 501–600 of 1,021
A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer
Zhang, X., Klamer, B. G., Li, J., Fernández, S., & Li, L. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0682-5 · Cited by 81
Long, X., Hou, H., Wang, X., Liu, S., Diao, T., Lai, S., Hu, M., Zhang, S., Liu, M., & Zhang, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02973-1 · Cited by 73
A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype
Chen, Z., Wang, M., Wilde, R. L. D., Feng, R., Su, M., la Roche, L. A. T.-D., & Shi, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749459 · Cited by 87
“Estimation of Stromal and Immune cells in Malignant Tumor Tissues Using Expression Data (ESTIMATE) is a method to predict immune scores, stromal scores, and tumor purity in tumor tissues by gene expression data (33).”
MethodInvestigating the utility of human melanoma cell lines as tumour models
Marie Vincent, K., & Postovit, L.-M. (2017) · Oncotarget · doi:10.18632/oncotarget.14443 · Cited by 69
“Stromal and Immune scores were defined for tumours through the use of the ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumour tissues using Expression data; original publication [31]) algorithm using RNASeqV2 data.”
MethodImmune-related prognosis biomarkers associated with osteosarcoma microenvironment
Hong, W., Yuan, H., Gu, Y., Liu, M., Ji, Y., Huang, Z., Yang, J., & Ma, L. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1165-7 · Cited by 70
Yu, G., Bao, J.-H., Zhan, M., Wang, J., Li, X., Gu, X., Song, S., Yang, Q., Liu, Y., Wang, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914577 · Cited by 77
“Estimate scores represent the aggregation of stromal scores and immune scores (37).”
BackgroundHuang, X., Zhou, S., Liu, Y., Tóth, J., & András, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978865 · Cited by 78
“This was done by the R package “ESTIMATE” in which the stromal score, immune score, and ESTIMATE score were calculated (42).”
MethodAssessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles
Vincent, K. M., Findlay, S. D., & Postovit, L.-M. M. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0613-0 · Cited by 69
“1c was largely responsible for the distance between tumours and cell lines, we correlated PC1 with stromal and immune scores in tumours as determined by using the ESTIMATE paradigm [27].”
MethodStover, D. G., Coloff, J. L., Barry, W. T., Brugge, J. S., Winer, E. P., & Selfors, L. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0471 · Cited by 79
“We calculated tumor purity for each sample using amethod that infers the fraction of stromal and immune cells in tumor samples, shown to correlate with tumor purity based on DNA copy number (26).”
MethodVarn, F. S., Tafe, L. J., Amos, C. I., & Cheng, C. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1431084 · Cited by 72
“23 In this dataset, expression-based measures of tumor purity as calculated by the ESTI-MATE algorithm 16 were negatively associated with immune in fi ltration, for all cell types, indicating that our in fi ltration scores were picking up expression signals from the tumor microenvironment (SCC range…”
MethodZhu, X., Sun, L., Song, N., He, W., Xie, B., Hu, J., Zhang, J., Yang, J., Dai, J., Bian, D., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02696-4 · Cited by 76
“For tumour micro-environment estimation, the immune score of each sample was calculated via the ‘ESTIMATE’ R package [21].”
MethodMalla, S. B., Byrne, R. M., Lafarge, M. W., Corry, S. M., Fisher, N. C., Tsantoulis, P. K., Mills, M. L., Ridgway, R. A., Lannagan, T. R. M., Najumudeen, A. K., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01654-5 · Cited by 73
Wang, Z., Liu, C., Zheng, S., Yao, Y., Wang, S., Wang, X., Yin, E., Zeng, Q., Zhang, C., Zhang, G., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.05.002 · Cited by 74
Sjödahl, G., Eriksson, P., Lövgren, K., Marzouka, N., Bernardo, C., Nordentoft, I., Dyrskjøt, L., Liedberg, F., & Höglund, M. (2018) · Modern Pathology · doi:10.1038/s41379-018-0096-5 · Cited by 69
Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer
Silberman, A., Goldman, O., Assayag, O. B., Jacob, A., Rabinovich, S., Adler, L. N., Lee, J. S., Keshet, R., Sarver, A., Frug, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1062 · Cited by 71
“To study the association between ASS1 and the hypoxic − gene expression in cancer, we first analyzed the Cancer Genome Atlas (TCGA) database for tumors expressing hypoxiarelated genes (16), in which the cancer cell purity was estimated to be >75% (15).”
MethodJohann, P. D., Jäger, N., Pfister, S. M., & Sill, M. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3014-z · Cited by 68
Integrative proteogenomic characterization of early esophageal cancer
Li, L., Jiang, D., Zhang, Q., Liu, H., Xu, F., Guo, C., Qin, Z., Wang, H., Feng, J., Liu, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37440-w · Cited by 67
Foy, J., Bazire, L., Ortiz‐Cuaran, S., Deneuve, S., Kielbassa, J., Thomas, E., Viari, A., Puisieux, A., Goudot, P., Bertolus, C., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0929-y · Cited by 70
Chen, C., Lu, Y., Cheng, A., Huang, C., Kuo, W., Wang, M., Chao, M., Chen, I., Kuo, C.-W., Lu, T., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0123 · Cited by 78
“The Estimation of Stromal and Immune Cells in Malignant Tumours Using Expression Data (ESTIMATE) algorithm was used to estimate the immune score, which inferred the abundance of infiltrating immune cells [36].”
MethodZhang, Y., Yang, M., Ng, D. M., Haleem, M., Yi, T., Hu, S., Zhu, H., Zhao, G., & Liao, Q. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.024 · Cited by 78
“To evaluate the tumor-associated effects of the infiltrating stromal and immune cells, the TME was preliminarily established based on the expression profiles from TCGA portal by using the ESTIMATE (estimation of stromal and immune cells in malignant tumor tissues using expression data) algorithm.(18) ESTIMATE generate…”
MethodYao, Y., Yan, Z., Lian, S., Wei, L., Chao Hui, Z. H. O. U., Feng, D., Zhang, Y., Yang, J., Li, M., & Chen, Y. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000444 · Cited by 78
Liu, D., Yang, X., & Wu, X.-Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663495 · Cited by 80
“The immune and stromal scores of each melanoma sample were calculated using the ESTIMATE method (17).”
MethodFang, Y. V., Wang, Y., Zeng, D., Zhi, S., Shu, T., Huang, N., Zheng, S., Wu, J., Liu, Y., Huang, G., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1951019 · Cited by 73
“ESTIMATE scores were calculated via the “ESTIMATE” R package, and the purity of each sample was evaluated using the formula described by Yoshihara et al.22”
MethodLu, X., Meng, J., Su, L., Jiang, L., Wang, H., Zhu, J., Huang, M., Cheng, W., Xu, L., Ruan, X., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.601 · Cited by 70
Xiao, Y., Yang, K., Wang, Z., Zhao, M., Deng, Y., Ji, W., Zou, Y., Qian, C., Liu, Y., Xiao, H., et al. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2021.775194 · Cited by 74
“Immune Infiltration Analysis Estimation of infiltrating stromal cells and immune cells in glioma samples was accomplished by the method ESTIMATE (15).”
MethodCao, K., Zhu, J., Lu, M., Zhang, J., Yang, Y., Ling, X., Zhang, L., Qi, C., Wei, S., Zhang, Y., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104920 · Cited by 75
“51 ICIs may show enhanced ef fi cacy in tumours with intrinsically high levels of in fi ltrating leukocytes.”
BackgroundStopfer, L. E., Flower, C. T., Gajadhar, A. S., Patel, B., Gallien, S., Lopez-Ferrer, D., & White, F. M. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3804 · Cited by 66
“6G), representative of the fraction of immune cells within a tumor sample (15, 57).”
BackgroundCao, R., Yuan, L., Ma, B., Wang, G., & Tian, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01362-0 · Cited by 83
“The immune scores, stromal scores and estimate scores from each sample were calculated by applying the “Estimation of STromal and Immune cells in MAlignant Tumours using Expression data” (ESTIMATE) algorithm [31].”
MethodXu, F., Zhan, X., Zheng, X., Xu, H., Li, Y., Huang, X., Lin, L., & Chen, Y. (2020) · Genomics · doi:10.1016/j.ygeno.2020.08.014 · Cited by 83
Wang, S., Pang, L., Liu, Z., & Meng, X. (2021) · BMC Cancer · doi:10.1186/s12885-021-08536-7 · Cited by 76
Zhu, M., Zeng, Q., Fan, T. T., Lei, Y., Wang, F., Zheng, S., Wang, X., Zeng, H., Tan, F., Sun, N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.783495 · Cited by 84
“Through CIBERSORT and ESTIMATE analyses, we quantified the abundance of 22 types of TIICs and the immune and stromal scores in every LUAD sample of the TCGA cohort.”
MethodBernardo, G., Noci, V. L., Ottaviano, E., Cecco, L. D., Camisaschi, C., Guglielmetti, S., Modica, M. D., Gargari, G., Bianchi, F., Indino, S., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216041 · Cited by 69
Lawrence, B. J., Blenkiron, C., Parker, K., Tsai, P., Fitzgerald, S. J., Shields, P., Robb, T. J., Yeong, M. L., Kramer, N., James, S., et al. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0058-3 · Cited by 66
Proteome‐based classification of Nonmuscle Invasive Bladder Cancer
Stroggilos, R., Mokou, M., Latosińska, A., Makridakis, M., Lygirou, V., Mavrogeorgis, E., Drekolias, D., Frantzi, M., Mullen, W., Fragkoulis, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32556 · Cited by 73
SMAC, a computational system to link literature, biomedical and expression data
Pirro, S., Gadaleta, E., Galgani, A., Colizzi, V., & Chelala, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-47046-2 · Cited by 65
Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
She, Y., Kong, X., Ge, Y., Yin, P., Liu, Z., Chen, J., Gao, F., & Fang, S. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1104-7 · Cited by 73
Yi, L., Huang, P. C., Zou, X., Guo, L., Gu, Y., Wen, C., & Wu, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105144 · Cited by 65
Identification of gastric cancer subtypes based on pathway clustering
Li, L., & Wang, X. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00186-z · Cited by 72
CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors
Shi, Z., Shen, J., Qiu, J., Zhao, Q., Hua, K., & Wang, H. (2021) · Theranostics · doi:10.7150/thno.59056 · Cited by 72
“cGAS-STING pathway and immune scores [32].”
Chen, D., Zhang, Y., Wang, W., Chen, H., Ling, T., Yang, R., Wang, Y., Duan, C., Liu, Y., Guo, X., et al. (2021) · Advanced Science · doi:10.1002/advs.202100311 · Cited by 71
Hurst, C. D., Cheng, G., Platt, F. M., Castro, M. A. A., Marzouka, N., Eriksson, P., Black, E. V. I., Alder, O., Lawson, A. R. J., Lindskrog, S. V., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100472 · Cited by 69
Chen, F., Yang, J., Fang, M., Wu, Y., Su, D., & Sheng, Y. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24302 · Cited by 80
Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity
Liu, T., Yang, K. Y., Chen, J., Qi, L.-M., Zhou, X., & Wang, P. (2023) · Biomolecules · doi:10.3390/biom13020326 · Cited by 68
““ESTIMATE”package in R was utilized to study the association between KIF18A expression and stromal cells and immune cells of 33 cancers [25].”
MethodAbelin, J. G., Bergstrom, E. J., Rivera, K. D., Taylor, H. B., Klaeger, S., Xu, C., Verzani, E. K., White, C. J., Woldemichael, H. B., Virshup, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37547-0 · Cited by 71
Shu, J., Jiang, J., & Zhao, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1177847 · Cited by 72
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
Vos, J. L., Burman, B., Jain, S., Fitzgerald, C. W. R., Sherman, E. J., Dunn, L. A., Fetten, J. V., Michel, L. S., Kriplani, A., Ng, K., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02518-x · Cited by 68
“Deconvolved immune signatures (ImmuneScore 29 , IIS 30 , CYT 31 , TIS 30 and REACTOME IFN-γ geneset 32 ) were consistently highest in SDC and low in ACC, although not statistically significant ( q = 0.18–0.30; Extended Data Fig.”
InfluentialOuyang, B., Shan, C., Shen, S., Dai, X., Chen, Q., Su, X., Cao, Y., Qin, X., He, Y., Wang, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51980-9 · Cited by 72
“Considering our previously hypothesized adjuvant role of GZMB on MG@PM-induced pyroptosis, we examined the immune micro-environment in metastatic tumor tissues of the lungs and noticed a distinct population of CD8 + T cells in MG@PM group (Supplementary Fig.39) 58,59 .”
InfluentialKnol, J. C., Lyu, M., Böttger, F., Monteiro, M. N., Pham, T. V., Rolfs, F., Vallés‐Martí, A., Schelfhorst, T., Haas, R. R. D. G., Bijnsdorp, I. V., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.003 · Cited by 68
Shah, S. H., Miller, P., García-Contreras, M., Ao, Z., Machlin, L., Issa, E., & El‐Ashry, D. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1071742 · Cited by 68
“This suggests that there may be significant stromal contribution to these hMAPKmiRNAs, as the presence of non-tumor stromal cells has been shown to strongly impact gene expression signatures.(53-57) Our results show that the hMAPK-miRNA signature significantly associates with tumors that have a high stromal score, as…”
BackgroundMethodResultInfluentialPanda, A., Betigeri, A. M., Subramanian, K., Ross, J. S., Pavlick, D. C., Ali, S. M., Markowski, P. A., Silk, A. W., Kaufman, H. L., Lattime, E. C., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00146 · Cited by 70
An integrated landscape of protein expression in human cancer
Jarnuczak, A. F., Najgebauer, H., Barzine, M., Kundu, D. J., Ghavidel, F., Perez-Riverol, Y., Papatheodorou, I., Brazma, A., & Vizcaíno, J. A. (2021) · Scientific Data · doi:10.1038/s41597-021-00890-2 · Cited by 63
Wang, J., Shen, C., Dong, D., Zhong, X., Wang, Y., & Yang, X. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107146 · Cited by 82
Jin, K., Qiu, S., Jin, D., Zhou, X., Zheng, X., Li, J., Liao, X., Yang, L., & Wei, Q. (2021) · Aging · doi:10.18632/aging.103787 · Cited by 72
Li, E., Yang, X., Du, Y., Wang, G., Chan, D. W., Wu, D., Xu, P., Ni, P., Xu, D., & Hu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667177 · Cited by 65
“The ESTIMATE score was calculated as the sum of combination the ImmuneScore and StromalScore, representing the combined proportions of these two components in the TME (17).”
MethodCai, Y., Ji, W., Sun, C., Xu, R., Chen, X., Deng, Y., Pan, J., Yang, J., Zhu, H., & Mei, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.704965 · Cited by 69
“defined ssGSEA based on the signatures related to stromal tissue and immune cell infiltration as Stromal and Immune scores and combined the stromal and immune scores as the ESTIMATE score, and Tumor Purity was defined as the relative proportion of tumor cells in a tumor tissue (18).”
MethodIntegrated proteogenomic characterization of medullary thyroid carcinoma
Xiao Hua, S. H. I., Sun, Y., Shen, C., Zhang, Y., Shi, R., Zhang, F., Liao, T., Lv, G., Zhu, Z., Jiao, L., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00479-y · Cited by 70
Jin, W., Yang, Q., Chi, H., Wei, K., Zhang, P., Zhao, G., Chen, S., Xia, Z., & Li, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1025330 · Cited by 77
“Estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) algorithm is a sophisticated algorithm which is designed for measuring the degree of infiltration of cancer cells and different normal cells by exploiting the unique properties of tumor cell transcriptional profiles (20)…”
BackgroundSonnenblick, A., Brohée, S., Fumagalli, D., Vincent, D., Venet, D., Ignatiadis, M., Salgado, R., den Eynden, G. V., Rothé, F., Desmedt, C., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0416-2 · Cited by 68
“Indeed, the Yoshiara stromal signature [26], which represents the fraction of “normal” stromal cells in tumor tissue, also correlated positively with the pSTAT3-GS.”
Qamra, A., Xing, M., Padmanabhan, N., Kwok, J. J. T., Zhang, S., Xu, C., Leong, Y. S., Lim, A. P. L., Tang, Q., Ooi, W. F., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1022 · Cited by 68
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction
Creech, A. L., Ting, Y. S., Goulding, S. P., Sauld, J. F. K., Barthelme, D., Rooney, M. S., Addona, T. A., & Abelin, J. G. (2018) · PROTEOMICS · doi:10.1002/pmic.201700259 · Cited by 65
Liu, R., Yang, F., Yin, J., Liu, Y., Zhang, W., & Zhou, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.685370 · Cited by 77
“To evaluate the immune score that measured the content of tumor-infiltrating immune cells in each patient across different datasets, ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data) was utilized (27).”
MethodHurvitz, S. A., Caswell-Jin, J. L., McNamara, K. L., Zoeller, J. J., Bean, G. R., Dichmann, R., Perez, A., Patel, R., Zehngebot, L. M., Allen, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19494-2 · Cited by 67
Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
Xu, S., Tang, L., Liu, Z., Luo, C., & Cheng, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.731048 · Cited by 76
“conducted to calculate the tumor purity of each sample by “estimate” R package (21).”
MethodWu, T., Wu, C., Zhao, X., Wang, G., Wei, N., Tao, Z., Chen, F., & Liu, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-07530-8 · Cited by 70
Zhou, W., Du, W.-D., Li, Y.-F., Al‐Aroomi, M. A., Yan, C., Wang, Y., Zhang, Z., Liu, F., & Sun, C.-F. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s364708 · Cited by 65
“Immune Infiltration Analysis We first analyse the correlation of FN1 expression with overall immune infiltration degree in TCGA-HNSCC patients by generating immunescore using ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data) algorithm.(27) Then, the association between…”
MethodPei, S., Zhang, P., Chen, H., Zhao, S., Dai, Y., Yang, L., Kang, Y., Zheng, M., Xia, Y., & Xie, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1135297 · Cited by 71
“The “estimate” R package allows users to determine the relative abundance of stromal cells, immune cells, and tumor cells (28) and then compare these values across different risk categories.”
BackgroundTran, K. A., Addala, V., Johnston, R. L., Lovell, D. R., Bradley, A. P., Koufariotis, L. T., Wood, S., Wu, S. Z., Roden, D. L., Al‐Eryani, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41385-5 · Cited by 70
Xu, S., Chen, Z., Chen, X., Chu, H., Huang, X., Chen, C., Liu, H., Qu, Y., & Lu, Z. (2025) · BMC Cancer · doi:10.1186/s12885-025-14246-1 · Cited by 65
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer
Huo, Q., Li, Z., Cheng, L., Yang, F., & Xie, N. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00621 · Cited by 69
“Tumor purity is an important factor affecting immune infiltration analysis of clinical tumor samples (36).”
BackgroundTargeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023) · MedComm · doi:10.1002/mco2.288 · Cited by 62
Song, W.-M., Agrawal, P., Von Itter, R., Fontanals-Cirera, B., Wang, M., Zhou, X., Mahal, L. K., Hernando, E., & Zhang, B. (2021) · Nature Communications · doi:10.1038/s41467-021-21457-0 · Cited by 62
Deng, X., Lin, D., Zhang, X., Shen, X., Yang, Z., Yang, L., Lu, X., Yu, L., Zhang, N., & Lin, J. J. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29633 · Cited by 76
“We employed the ESTIMATE algorithm to calculate immune and stromal scores for each sample (Yoshihara et al., 2013).”
MethodWu, M., Shang, X., Sun, Y., Wu, J., & Liu, G. (2020) · PeerJ · doi:10.7717/peerj.8961 · Cited by 66
Systematic Assessment of Tumor Purity and Its Clinical Implications
Haider, S., Tyekucheva, S., Prandi, D., Fox, N. S., Ahn, J., Xu, A. W., Pantazi, A., Park, P. J., Laird, P. W., Sander, C., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00016 · Cited by 70
Self-citationPan‐cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators
Wu, C., Tan, J., Wang, X., Qin, C., Long, W., Pan, Y., Li, Y., & Liu, Q. (2022) · iMeta · doi:10.1002/imt2.68 · Cited by 70
“…infiltration), and ESTIMATE-Score (negatively correlated with tumor purity) were inferred for each tumor sample using the ESTIMATE algorithm [83], and the correlation between the cuprop-tosis activity score and these three were calculated for each tumor type using Spearman's correlation…”
MethodProteogenomic characterization of MiT family translocation renal cell carcinoma
Qu, Y., Wu, X., Anwaier, A., Feng, J., Xu, W., Pei, X., Zhu, Y., Liu, Y., Bai, L., Yang, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34460-w · Cited by 64
Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets
Large, T. Y. S. L., Mantini, G., Meijer, L. L., Pham, T. V., Funel, N., van Grieken, N. C. T., Kok, B., Knol, J. C., van Laarhoven, H. W. M., Piersma, S. R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138290 · Cited by 66
“Bioinformatics efforts to delineate the compartment-specific expression have overcome this problem partially and increased our understanding of tumor biology (3).”
BackgroundLee, W., Reuben, A., Hu, X., McGranahan, N., Chen, R., Jalali, A., Negrao, M. V., Hubert, S. M., Tang, C. Z., Wu, C.-C., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02175-0 · Cited by 66
“We first applied ESTIMATE, an algorithm estimating infiltration of overall immune cells [33], and the analysis revealed significantly lower ESTIMATE scores in metastases than primary tumors (Fig.”
MethodTranscriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer
Liu, W., Ye, H., Liu, Y., Xu, C., Zhong, Y., Tian, T., Ma, S., Tao, H., Li, L., Xue, L., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7855 · Cited by 68
“ESTIMATE algorithm exploits the unique properties of the transcriptional profiles of cancer samples to infer tumor cellularity and identify the infiltrating normal cells (6).”
Xie, F., Zhang, J. J., Wang, J., Reuben, A., Xu, W., Yi, X., Varn, F. S., Ye, Y., Cheng, J., Yu, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1744 · Cited by 66
“Tumor purity was calculated from each TCGA patient gene expression pro fi le using the ESTIMATE algorithm (43).”
MethodComprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma
Chen, H., Xu, C., Yu, Q., Chen, Z., Peng, Y., Chen, J., & Chen, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30060 · Cited by 73
“In addition, based on expression data, immune score, stromal score, and ESTIMATE score of each GBM patients were analyzed by R packages “estimate” to access the infiltration level of immune cells and the level of stromal cells in tumor tissues (Yoshihara et al., 2013).”
MethodOtani, Y., Yoo, J. Y., Lewis, C. T., Chao, S., Swanner, J. L., Shimizu, T., Kang, J. M., Murphy, S. A., Rivera-Caraballo, K., Hong, B., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2347 · Cited by 62
Cai, J., Hu, Y., Ye, Z., Ye, L., Gao, L., Wang, Y., Sun, Q., Tong, S., Yang, J., & Chen, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011757 · Cited by 61
“described an ESTIMATE method to assess the score of stromal and immune cells in tumour samples, and the score was positively related to tumour purity (24).”
MethodA proteogenomics data-driven knowledge base of human cancer
Liao, Y., Savage, S. R., Dou, Y., Shi, Z., Yi, X., Jiang, W., Lei, J. T., & Zhang, B. (2023) · Cell Systems · doi:10.1016/j.cels.2023.07.007 · Cited by 67
Han, Z., Zhang, Z., Yang, X., Li, Z., Sang, S., Islam, M. T., Guo, A. A., Li, Z., Wang, X., Wang, J., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-008927 · Cited by 68
Mao, Y., Shen, J., Lu, Y., Lin, K., Wang, H., Li, Y., Chang, P., Walker, M. G., & Li, D. (2017) · Oncotarget · doi:10.18632/oncotarget.16451 · Cited by 64
“To measure the fraction of stromal and immune cells in tumor samples, we applied the ESTIMATE method [37] in our data analysis.”
MethodFaden, D. L., Ding, F., Lin, Y., Zhai, S., Kuo, F., Chan, T. A.-T., Morris, L. G. T., & Ferris, R. L. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.07.020 · Cited by 63
Li, J., Li, X., Zhang, C., Zhang, C., & Wang, H. (2020) · Oncology Reports · doi:10.3892/or.2020.7464 · Cited by 68
“Several reports have demonstrated that immune scores and stromal scores calculated based on the ESTIMATE algorithm could predict the infiltration of non‐tumor cells, by analyzing specific gene expression signature of immune and stromal cells (10-13).”
BackgroundHam, I., Lee, D., & Hur, H. (2021) · Cancers · doi:10.3390/cancers13051172 · Cited by 64
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
Isaacs, J. M., Anders, C. K., McArthur, H. L., & Force, J. M. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00833-4 · Cited by 64
Liu, Z., Lu, T., Li, J., Wang, L., Xu, K., Dang, Q., Liu, L., Guo, C., Jiao, D., Sun, Z., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702594 · Cited by 78
“First, we leveraged the R package ESTIMATE to infer the fraction of stromal and immune cells in CRC samples, and generated two scores including the immune and stromal scores (32).”
MethodZhou, P., Wei, J., Yuhua, L., Wang, L., & Zhang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.661758 · Cited by 76
“We applied the ESTIMATE method to evaluate the presence of stromal cells and immune cells in the TME by calculating specific gene expression data (9).”
MethodYu, Z., Zhang, J., Zhang, Q., Wei, S., Shi, R., Zhao, R., An, L., Grose, R. P., Feng, D., & Wang, H. (2022) · Cell Proliferation · doi:10.1111/cpr.13249 · Cited by 64
“The ESTIMATE score was derived by combined Stromal score and Immune score to predict the tumour purity.(24) The C3 cluster with the lowest stroma score calculated using the Estimate R package was associated with prolonged survival (Figure 5C).”
MethodMartínez, E., Yoshihara, K., Kim, H., Mills, G. M., Treviño, V., & Verhaak, R. G. W. (2014) · Oncogene · doi:10.1038/onc.2014.216 · Cited by 78
Self-citationProgress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies
Filipović, A., Miller, G., & Bolen, J. B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00155 · Cited by 64
“To address this challenge, ESTIMATE (Yoshihara et al., 2013) and CIBERSORT (Chen B. et al., 2018) as novel methodologies using computational approaches tend to distinguish gene expression signatures and assign them to the distinct fractions of tumor cells, immune or stromal cells.”
MethodFukumura, K., Malgulwar, P. B., Fischer, G. M., Hu, X., Mao, X., Song, X., Hernandez, S. D., Zhang, X. H.-F., Zhang, J., Parra, E. R., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02256-1 · Cited by 62
“To further define the microenvironmental distinctions underlying the transcriptional evidence of immune suppression in BM, we analyzed our mRNA-seq data using two computational algorithms: Estimation of Stromal and Immune Cells in Malignant Tumor Tissues Using Expression Data (ESTIMATE) and Microenvironmental Cell Pop…”
MethodThe vascular landscape of human cancer
Kahn, B. M., Lucas, A., Alur, R. G., Wengyn, M. D., Schwartz, G. W., Li, J., Sun, K., Maurer, H. C., Olive, K. P., Faryabi, R. B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136655 · Cited by 54
“35 and Supplemental Figure 5F), suggesting that the stromal content may potentially be a covariant in these survival analyses.”
Wang, T., Dang, N., Tang, G., Li, Z., Li, X., Shi, B., Xu, Z., Li, L., Yang, X., Xu, C., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13190 · Cited by 65
Zheng, S., Liang, J., Tang, Y., Xie, J., Zou, Y., Yang, A., Shao, N., Kuang, X., Ji, F., Liu, X., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1189 · Cited by 68
Sheng, D., Yue, K., Li, H., Zhao, L., Zhao, G., Jin, C., & Zhang, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03549-22 · Cited by 62
“The estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) (68) is a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumor samples.”
Method
Metadata
- Authors
- Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., Carter, S. L., Getz, G., Stemke-Hale, K., Mills, G. B., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Memorial Sloan Kettering Cancer Center (US)
- Broad Institute (US)
- Corresponding author
- Verhaak, Roel G.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-11
- Volume
- 4
- Issue
- 1
- Pages
- 2612-2612
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3826632
- OpenAlex
- W2130430382
- Cited by
- 9,778
- References
- 63
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 1602 · 2023: 1755 · 2022: 1988 · 2021: 1316 · 2020: 683 · 2019: 223 · 2018: 121 · 2017: 93 · 2016: 53 · 2015: 39 · 2014: 20 · 2013: 2
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (P50CA098258, U24CA143882, CA143883, U24CA143883, P30CA008748, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- tumor purity, tumor stroma, tumor-infiltrating immune cells, gene expression signatures, tumor microenvironment, DNA copy number, cancer transcriptomics
- MeSH terms
- Algorithms, Cell Separation, Female, Humans, Leukocytes, Neoplasms, Research Design, Sensitivity and Specificity, Software, Gene Library, Genome, Human, Stromal Cells, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, DNA Copy Number Variations, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.